Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Moreira

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
BJU International|September 24, 2010
A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseHoward S Kim, Daniel M Moreira, Matthew R Smith, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomyRoss M Simon, Lauren E Howard, Daniel M Moreira, et al.
BJU International|April 4, 2017
Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancerLauren E Howard, Daniel M Moreira, Amanda De Hoedt, et al.
Urology|July 24, 2017
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical RecurrenceStephanie L Skove, Lauren E Howard, William J Aronson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 2018
Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE TrialEmma H Allott, Sarah C Markt, Lauren E Howard, et al.
The Journal of Urology|February 19, 2021
Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical TrialPaige K Kuhlmann, Sean C Fischer, Lauren E Howard, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 1, 2010
Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databasesDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
BJU International|September 9, 2015
To clamp or not to clamp? Long-term functional outcomes for elective off-clamp laparoscopic partial nephrectomyParas H Shah, Arvin K George, Daniel M Moreira, et al.
Endoscopic Ultrasound|May 29, 2015
Utility of EUS following endoscopic polypectomy of high-risk rectosigmoid lesionsLeticia P Luz, Gregory A Cote, Mohammad A Al-Haddad, et al.
Prostate Cancer and Prostatic Diseases|May 26, 2018
PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE studyDevin N Patel, Tom Feng, Ross M Simon, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
BJU International|September 24, 2010
A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseHoward S Kim, Daniel M Moreira, Matthew R Smith, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 12, 2017
Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomyRoss M Simon, Lauren E Howard, Daniel M Moreira, et al.
BJU International|April 4, 2017
Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancerLauren E Howard, Daniel M Moreira, Amanda De Hoedt, et al.
Urology|July 24, 2017
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical RecurrenceStephanie L Skove, Lauren E Howard, William J Aronson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 2018
Geographic Differences in Baseline Prostate Inflammation and Relationship with Subsequent Prostate Cancer Risk: Results from the Multinational REDUCE TrialEmma H Allott, Sarah C Markt, Lauren E Howard, et al.
The Journal of Urology|February 19, 2021
Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical TrialPaige K Kuhlmann, Sean C Fischer, Lauren E Howard, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 1, 2010
Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databasesDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
BJU International|September 9, 2015
To clamp or not to clamp? Long-term functional outcomes for elective off-clamp laparoscopic partial nephrectomyParas H Shah, Arvin K George, Daniel M Moreira, et al.
Endoscopic Ultrasound|May 29, 2015
Utility of EUS following endoscopic polypectomy of high-risk rectosigmoid lesionsLeticia P Luz, Gregory A Cote, Mohammad A Al-Haddad, et al.
Prostate Cancer and Prostatic Diseases|May 26, 2018
PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE studyDevin N Patel, Tom Feng, Ross M Simon, et al.
Pageof 15